{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"44.9","value":"98.2"},{"groupId":"OG001","spread":"44.2","value":"65.7"},{"groupId":"OG002","spread":"148","value":"132"},{"groupId":"OG003","spread":"188","value":"213"},{"groupId":"OG004","spread":"322","value":"293"},{"groupId":"OG005","spread":"482","value":"410"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"14"},{"groupId":"OG004","value":"11"},{"groupId":"OG005","value":"5"}],"units":"Participants"}],"dispersionType":"Standard Deviation","groups":[{"description":"INCB053914 will be self-administered orally once a day as a 100mg immediate release monotherapy dose.","id":"OG000","title":"Parts 1 and 2: INCB053914 100 mg QD"},{"description":"INCB053914 will be self-administered orally twice day as a 50mg immediate release monotherapy dose.","id":"OG001","title":"Parts 1 and 2: INCB053914 50 mg BID"},{"description":"INCB053914 will be self-administered orally twice day in as a 65mg immediate release monotherapy dose","id":"OG002","title":"Parts 1 and 2: INB053914 65 mg BID"},{"description":"INCB053914 will be self-administered orally twice day in as a 80mg immediate release monotherapy dose.","id":"OG003","title":"Parts 1 and 2: INB053914 80 mg BID"},{"description":"INCB053914 will be self-administered orally twice day as a 100mg immediate release monotherapy dose.","id":"OG004","title":"Parts 1 and 2: INB053914 100 mg BID"},{"description":"INCB053914 will be self-administered orally twice day as a 115mg immediate release monotherapy dose.","id":"OG005","title":"Parts 1 and 2: INB053914 115 mg BID"}],"paramType":"MEAN","populationDescription":"Ctau was calculated using the predose value on C1D8","reportingStatus":"POSTED","timeFrame":"Cycle 1 Day 8","title":"Pharmacokinetics: Ctau of INCB053914 Monotherapy","type":"SECONDARY","unitOfMeasure":"L/h"}